Effect of Lipodox in combination with bevacizumab in a patient with a metastatic malignant phyllodes breast tumor: A case report
Authors:
Open Access
- 28 September 2017
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (6) , 6685-6689
Abstract
A 76‑year‑old female patient with a malignant phyllodes tumor underwent modified radical mastectomy and wide excision. Multiple nodules were observed in the operated wound area. Positron emission tomography‑computed tomography (PET‑CT) revealed recurrent disease in the left breast, the adjacent left third rib, the left internal mammary region and the left ilium. A novel formulation of bevacizumab (5 mg/m2, first day) in combination with liposomal doxorubicin (Lipodox, 30 mg/m2, second day) was administered for 3 cycles every 2 weeks, and subsequently wide excision was performed. Lipodox (40 mg/m2) was administered for 3 cycles every 3 weeks, starting 4 weeks after the surgery. Follow‑up whole body PET‑CT scanning, 3 and 6 months later, indicated no sign of residual hypermetabolic malignancy. Malignant phyllodes tumors do not usually respond to chemotherapy or radiotherapy. In the present case report, a novel formulation of bevacizumab in combination with Lipodox was administered as neoadjuvant chemotherapy in a patient with a malignant phyllodes tumor and preoperative tumor shrinkage was achieved, resulting in clear resection margins.Keywords
This publication has 15 references indexed in Scilit:
- Successful Preoperative Chemoembolization in the Treatment of a Giant Malignant Phyllodes TumorCardioVascular and Interventional Radiology, 2016
- VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedsideOncotarget, 2016
- Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled TrialsPLOS ONE, 2015
- Effects of adjuvant radiotherapy on borderline and malignant phyllodes tumors: A systematic review and meta-analysisMolecular and Clinical Oncology, 2015
- Aggressive malignant phyllodes tumorInternational Journal of Surgery Case Reports, 2015
- Utilization of Radiotherapy for Malignant Phyllodes Tumors: Analysis of the National Cancer Data Base, 1998–2009Annals of Surgical Oncology, 2013
- Management of non metastatic phyllodes tumors of the breast: Review of the literatureSurgical Oncology, 2011
- Management of Phyllodes Breast TumorsThe Breast Journal, 2011
- Phyllodes Tumor of the BreastInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Surgical treatment of phyllodes tumors of the breast: Retrospective review of 172 casesJournal of Surgical Oncology, 2005